Simone A. Glynn
National Institutes of Health
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Simone A. Glynn.
Transfusion | 2005
Michael P. Busch; Simone A. Glynn; Susan L. Stramer; D. Michael Strong; Sally Caglioti; David Wright; Brandee L. Pappalardo; Steven H. Kleinman
BACKGROUND: Estimates for human immunodeficiency virus (HIV)‐1 and hepatitis C virus (HCV) transfusion‐transmitted risks have relied on incidence derived from repeat donor histories and imprecise estimates for infectious, preseroconversion window periods (WPs).
Transfusion | 2009
Darrell J. Triulzi; Steven H. Kleinman; Ram Kakaiya; Michael P. Busch; Philip J. Norris; Whitney R. Steele; Simone A. Glynn; Christopher D. Hillyer; Patricia M. Carey; Jerome L. Gottschall; Edward L. Murphy; Jorge A. Rios; Paul M. Ness; David Wright; Danielle M. Carrick; George B. Schreiber
BACKGROUND: Antibodies to human leukocyte antigens (HLA) in donated blood have been implicated as a cause of transfusion‐related acute lung injury (TRALI). A potential measure to reduce the risk of TRALI includes screening plateletpheresis donors for HLA antibodies. The prevalence of HLA antibodies and their relationship to previous transfusion or pregnancy in blood donors was determined.
Transfusion | 2002
Simone A. Glynn; Steven H. Kleinman; George B. Schreiber; Thomas F. Zuck; Suzanne Mc Combs; James Bethel; George Garratty; Alan E. Williams
BACKGROUND: Understanding blood donor motivations is crucial to improving effectiveness of donor recruitment and retention programs.
Transfusion | 2003
Steven H. Kleinman; Mary C. Kuhns; Deborah Todd; Simone A. Glynn; Anne L. McNamara; Anthony DiMarco
BACKGROUND: An estimate of the rate of HBV DNA‐positive, anti‐HBc‐positive units is important for evaluating the need for anti‐HBc donor screening, especially in the context of HBV NAT.
Nutrition and Cancer | 1994
Simone A. Glynn; Demetrius Albanes
Folate, a water-soluble vitamin, part of the vitamin B complex, plays an important role in methylation reactions and DNA/RNA synthesis. This review examines the experimental and epidemiological evidence for the association between folate status and risk of cancer. Data have accumulated indicating that low folate status may promote carcinogenesis. Low folate levels are associated with cytogenetic abnormalities in vivo and in vitro. Findings from animal studies are conflicting and suggest that the effect of folate on neoplasia depends on factors such as the animal and tumor model, the type, timing, dose, and length of application of carcinogen, the stage of carcinogenesis, and the level and form of folate administered. Epidemiological studies examined the association between folate and cancer of the cervix, colorectum, lung, esophagus, and brain and suggest that low folate status may play an important role early in the neoplastic process. The potential for inhibition of precursor lesions in the cervix and colorectum, namely, cervical intraepithelial neoplasia and adenomatous polyps, respectively, is of particular interest. Additional research designed to clarify the role of folate in carcinogenesis is warranted.
Transfusion | 2006
George B. Schreiber; Karen S. Schlumpf; Simone A. Glynn; David Wright; Yongling Tu; Melissa King; Martha J. Higgins; Debra Kessler; Ronald O. Gilcher; Catharie C. Nass; Anne M. Guiltinan
BACKGROUND: To prevent donor loss and improve retention, it is important to understand the major deterrents to blood donation and to identify factors that can be effectively addressed by blood centers.
Transfusion | 2011
Ritchard G. Cable; Simone A. Glynn; Joseph E. Kiss; Alan E. Mast; Whitney R. Steele; Edward L. Murphy; David J. Wright; Ronald A. Sacher; Jerry L. Gottschall; Vibha Vij; Toby L. Simon
BACKGROUND: Regular blood donors are at risk of iron deficiency, but characteristics that predispose to this condition are poorly defined.
Emerging Infectious Diseases | 2006
Michael P. Busch; David Wright; Brian Custer; Leslie H. Tobler; Susan L. Stramer; Steven H. Kleinman; Harry E. Prince; Celso Bianco; Gregory A. Foster; Lyle R. Petersen; George J. Nemo; Simone A. Glynn
Routine donor nucleic acid amplification testing is a valuable surveillance screening tool.
Transfusion | 2012
Ritchard G. Cable; Simone A. Glynn; Joseph E. Kiss; Alan E. Mast; Whitney R. Steele; Edward L. Murphy; David J. Wright; Ronald A. Sacher; Jerry L. Gottschall; Leslie H. Tobler; Toby L. Simon
BACKGROUND: Blood donors are at risk of iron deficiency. We evaluated the effects of blood donation intensity on iron and hemoglobin (Hb) in a prospective study.
Transfusion | 2007
Whitney R. Steele; George B. Schreiber; Anne M. Guiltinan; Catharie C. Nass; Simone A. Glynn; David Wright; Debra Kessler; Karen S. Schlumpf; Yongling Tu; James W. Smith; George Garratty
BACKGROUND: Blood donation can be described as a prosocial behavior, and donors often cite prosocial reasons such as altruism, empathy, or social responsibility for their willingness to donate. Previous studies have not quantitatively evaluated these characteristics in donors or examined how they relate to donation frequency.